Abstract
Cancer is the second leading cause of death in the United States. It i s estimated that approximately a third of all Americans will develop cancer in their lifetime. The American Cancer Society estimated that 1,220,000 new cases of cancer and 550,000 deaths occurred in 2000 (see www.cancer.org). Agents that can cause cancer are called carcinogens. Carcinogens can be classified into agents that are chemical, viral, or physical (radiation such as untraviolet [UV] light, X-rays, and gamma rays). Approximately 60–90% of all cancers are now generally believed to be due to these environmental factors to which humans are exposed in food, water, or air. It is important to mention that the term environmental factors includes both natural and human-made agents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Searle, C. E. (ed.) (1984) Chemical Carcinogens, 2nd ed. (ACS Monograph 182 ), American Chemical Society, Washington DC.
Politzer, P. and Martin, F. J. (eds.) (1988) Chemical Carcinogens. (Bioactive Molecules, vol. 5 ), Elsevier, New York.
Bowman, M.C. (ed.) (1982) Handbook of Carcinogens and Hazardous Substances. Marcel Dekker, Inc., New York.
Bartsch, H., Hemminli, K., and O’Neill, I. K. (eds.) (1988) Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention. International Agency for Research on Cancer, Lyon, France.
Milman, H. A. and Weisburger, E. K. (eds.) (1985) Handbook of Carcinogen Testing. Noyes Publications, Park Ridge, NJ.
Montesano, R., Bartsch, H., Vainio, H., Wilbourn, J., and Yamasaki, H. (eds.) (1986) Long-term and Short-term Assays for Carcinogens: A Critical Appraisal. International Agency for Research on Cancer, Lyon, France.
Harvey, R. G. (1997)Polycy clic AromaticHydrocarbons: Chemistry and Cancer. Wiley-VCH, Inc., New York, New York.
Singer, B. and Grunberger, D. (1983) Molecular Biology of Mutagens and Carcinogens. Plenum Press, New York.
Redmond, D. E., Jr. (1970) Tobacco and Cancer: the first clinical report, 1761. N. Engl. J. Med. 282: 18–23.
Pott, P. (1963) Chirurgical observations relative to the cancer of the scrotum. London, 1775. Natl. Cancer Inst. Monograph 10: 7–13.
Yamagiwa, K. and Ichikawa, K. (1915) Verh. Japn. Path. Ges. 5: 142–148.
Kennaway, E. L. and Hieger, I. (1930) Carcinogenic substances and their fluorescent spectra. BMJ ii: 1044–1046.
Cook. J. W., Hewett, C. L., and Hieger, I. (1933) The isolation of a cancer-producing hydrocarbon from coal tar, Parts I-III. J. Chem. Soc. 395–405.
Hueper, W. C. (1942) Occupational Tumors and Allied Diseases. Thomas Co., Springfield IL.
Hueper, W. C., Wiley, F. H., and Wolfe, H. D. (1938) Experimental production of bladder tumors in dogs by administration of betanaphthylamine. J. Ind. Hyg. Toxicol. 20: 46–84.
Rehn, L. (1895) Blasengeschwulste bei fuchsinarbeitern. Arch. Klin. Chir. 50: 588–600.
Case, R. A. M., Hosker, M. W., McDonald, D. B., and Pearson, J. T. (1954) Tumors of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical inductry. Br. J. Ind. Med. 11: 75–104.
Doll, R. and Peto, R. (1981) The Causes of Cancer. Oxford Press, New York.
Schulte, P. A., Ward, E., Boeniger, M., and Hills, B. (1988) Occupational exposure to N-substituted aryl compounds. In: Carcinogenic and Mutagenic Responces to Aromatic Amines and Nitroarenes ( King, C. M., Romano, L. J. and Schuetzle, D., eds.), Elsevier Science, New York, pp. 23–35.
Guerin, M. R. and Buchanan, M. V. (1988) Environmental exposure to N-substituted aryl compounds. In: Carcinogenic and Mutagenic Responces to Aromatic Amines and Nitroarenes ( King, C. M., Romano, L. J. and Schuetzle, D., eds.), Elsevier Science, New York, pp. 37–45.
Ross, R. K., Paganini-Hill, A. and Henderson, B. E. (1988) Epidemeology of bladder cancer. In: Diagnosis and Management of Genitourinary Cancer ( Skinner, D. G. and Lieshovsky, G., eds.), W.B. Saunders Co., Philadephia, pp. 23–31.
Asao, T., Buchi, G., Abdel-Kader, M. M., Chang, S. B., Wick, E. L., and Wogan, G. N. (1963) Aflatoxins B and G. J. Am. Chem. Soc. 85: 1706–1707.
Eaton, D. L. and Groopman, J. D. (eds.) (1994) The Toxicology of Aflatoeins. Academic Press, New York.
Muller, F. H. (1939) Tobacco abuse and carcinoma of the lung. Z. Krebsforsch. 49: 57–85.
Doll, R. and Hill, A. B. (1950) Smoking and carcinoma of the lung. Br. Med. J. ii: 739–748.
Peto, R. (1986) Tobacco: an overview of health effects. In: Tobacco. A Major International Health Hazard ( Zaridze, D. G. and Peto, R., eds.), International Agency for Research on Cancer, Lyon, France, pp. 12–22.
Hoffmann, D. and Hoffmann, I. (1997) The changing cigarette, 1950–1995. J. Toxicol. Environ. Health 50: 307–364
Holleb, H. B. and Angrist, A. (1942) Bronchiogenic carcinoma in association with pulmonary asbestosis. Am. J. Pathol. xviii: 123.
Selikoff, I. and Hammond, E. C. (1978) Asbestos-associated diseases in the United States shipyards. Cancer 28: 67–99.
Blair, A. and Kazerouni, N. (1997) Reactive chemicals and cancer. Cancer Causes Control 8: 473–490.
Higginson, J. (1969) Present trends in cancer epidemiology. Canadian Cancer Conf. 8: 40–75.
Haenszel, W. and Kurihara, M. (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J. Natl. Cancer Inst. 40: 43–68.
Haenszel, W. (1975) Migrant studies. In: Persons at High Risk of Cancer. An approach to Cancer Etiology and Control. ( Fraumeni Jr., J. F., ed.), Academic Press, New York, pp. 361–371.
Boveri, T. (1914) Zur frage der entstehung maligner tumoren. Gustave Fischer Verlag, Jena, Germany.
Crow, J. F. and Abrahamson S. (1997) Seventy years ago: mutation becomes experimental. Genetics 147: 1491–1496.
McCann, J., Choi, E., Yamasaki, E., and Ames, B. N. (1975) Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72:5135–5139.
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., et al. (1982) Mechanism of activation of a human oncogene. Nature 300: 143–149.
Reddy, E. P., Reynolds, R. K., Santos, E., and Barbacid, M. (1982) A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature 300: 149–152.
Taparowsky, E., Suard, Y., Fasano, O., Shimizu, K., Goldfarb, M., and Wigler, M. (1982) Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change. Nature 300: 762–765.
Vogelstein, B., and Kinzler, K. W. (1992) Carcinogens leave fingerprints. Nature 355: 209–210.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994) Perspectives in Cancer Research: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54: 4855–4878.
Hainaut, P., Hernandez, T., Robinson, A., Rodriguez-Tome, P., Flores, T., Hollstein, M., et al. (1998) IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Res. 26: 205–213.
Ortiz de Montellano, P. R. (ed.) (1995) Cytochrome P450: Structure, Mechanism, and Biochemistry, 2nd ed., Plenum Press, New York.
Schenkman, J. B. and Greim, H. (eds.) (1993) Cytochrome P450. Springer-Verlag, New York.
Jakoby, W. B., Bend, J. R., and Caldwell, J. (eds.) (1982) Metabolic Basis of Detoxification: Metabolism of Functional Groups. Academic Press, New York.
Caldwell, J. and Jakoby, W. B. (eds.) (1983) Metabolic Basis of Detoxification. Academic Press, New York.
Jakoby, W. B. (ed.) (1980) Enzymatic Basis of Detoxification. Academic Press, New York.
Miller, E. C. (1978) Some current perspectives on chemical carcinogenesis in humans and experimental animals: presidential address. Cancer Res. 38: 1479–1496.
Nelson, D. R., Koymans, L., Kamataki, T., Stegemann, J. J., Feyereisen, R., Waxman, D. J., et al. (1996) P450 superfamily: update on new sequences, gene mapping, accession numbers and nomeclature. Pharmacogenetics 6: 1–42.
Correia, M. A. (1995) Rat and human liver cytochrome P450. Substrate and inhibitor specificities and functional markers. In: Cytochrome P450: Structure, Mechanism, and Biochemistry. ( Ortiz de Montellano, P. R., ed.), Plenum Press, New York, pp. 607–630.
Guengerich, F. P. (1995) Human cytochrome P450 enzymes. In: Cytochrome P450: Structure, Mechanism, and Biochemistry. ( Ortiz de Montellano, P. R., ed.), Plenum Press, New York, pp. 473–535.
Harvey, R. G. (1991) Polycyclic Aromatic Hydrocarbons: Chemistry and Cancer, Cambridge University Press, Cambridge, UK.
Phillips, D. H. (1983) Fifty years of benzo[a]pyrene. Nature 303: 468–472.
Conney, A. H. (1982) Induction ofmicrosomal enzymes by foreign chemicals and carcinogens by polycyclic aromatic hydrocarbons. Cancer Res. 42: 4875–4917.
Preussmann, R. and Stewart, B. W. (1984) N-nitroso carcinogens. In: Chemical Carcinogens, 2nd ed. (ACS Monograph I82), ( Searle, C. E., ed.), American Chemical Society, Washington DC, pp. 643–828.
Preussmann, R. and Eisenbrand, G. (1984) N-nitroso carcinogens in the environment. In: Chemical Carcinogens, 2nd ed. (ACS Monograph 182), ( Searle, C. E., ed.), American Chemical Society, Washington DC, pp. 829–868.
Whitlock, J. P., Jr. and Denison, M. S. (1995) Induction of cytochrome P450 enzymes that metabolize xenobiotics. In: Cytochrome P450: Structure, Mechanism, and Biochemistry ( Ortiz de Montellano, P.R., ed.), Plenum Press, New York, pp. 367–390.
Jakoby, W. B. and Ziegler, D. M. (1990) The enymes of detoxification. J. Biol. Chem. 265: 20715–20718.
Miller, J. A. and Surh, Y.-J. (1994) Historical perspectives on conjugate-dependent bioactivation of foreign compounds. Adv. Pharmacol. 27: 1–16.
Andersson, C., Mosialou, E., Weinander, R., and Morgenstern, R. (1994) Enzymology of microsomal glutathione S-transferase. Adv. Pharmacol. 27: 19–35.
Ketterer, B. and Christodoulides, L. G. (1994) Enzymology of cytosolic glutathione S-transferase. Adv. Pharmacol. 27: 37–51.
Commandeur, J. N. M., Stijntjes, G. J., and Vermeulen, N. P. E. (1995) Enzymes and transport systems involved in the formation and disposition of glutathione S-conjugates. Pharmacol. Rev. 47: 271–330.
Zia-Amirhosseini, P., Spahn-Langguth, H., andBenet, L. Z. (1994) Bioactivation by glucuronide-conjugate formation. Adv. Pharmacol. 27: 385–397.
Bock, K. W. (1994) UDP-glucuronosyltransferases and their role in metabolism and disposition of carcinogens. Adv. Pharmacol. 27: 367–383.
Tephly, T. R. and Burchell, B. (1990) UDP-glucuronosyltransferases: a family of detoxifying enzymes. Trends Pharmacol. Sci. 11: 276–279.
Coughtrie, M. W. H., Bamforth, K. J., Sharp, S., Jones, A. L., Borthwick, E. B., Barker, E. V., et al. (1994) Sulfation of endogenous compounds and xenobiotics: interactions and function in health and disease. Chem. Biol. Interactions 92: 247–256.
Matsui, M. and Homma H. (1994) Biochemistry and molecular biology of drug-metabolizing sulfotransferase. Int. J Biochem. 26: 1237–1247.
Falany, C. N. and Wilborn, T. W. (1994) Biochemistry of cytosolic sulfotransferases involved in bioactivation. Adv. Pharmacol. 27: 301–330.
Machejda, C. J. and Koepke, M. B. K. (1994) Carcinogen activation by sulfate conjugate formation. Adv. Pharmacol. 27: 331–362.
Hanna, P. E. (1995)N-acetyltransferases, 0-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation. Pharmacol. Rev. 47: 401–430.
King, C. M., Land, S. J., Jones, R. F., Debiec-Rychter, M., Lee, M.-S., and Wang, C. Y. (1997) Role of acetyltransferases in the metabolism and carcinogenicity of aromatic amines. Mut. Res. 376: 123–128.
Grant, D. M., Hughes, N. C., Janezic, S. A., Goodfellow, G. H., Chen, H. J., Gaedigk, A., et al. (1997) Human acetyltransferase polymorphisms. Mut. Res. 376: 61–70.
Ozawa, N. and Geungerich, F. P. (1983) Evidence for formation of an S-[2-(N7-guanyl)ethyl]glutathione adduct in glutathione-mediated binding of the carcinogen 1,2-dibromoethane to DNA. Proc. Natl. Acad. Sci. USA 80: 5266–5270.
Kim, M. S. and Guengerich, F. P. (1997) Synthesis of oligonucleotides containing the ethylene dibromide DNA adducts S-[2-(N7guanyl)ethyl]glutathione, S-[2-(N2-guanyl)ethyl]glutathione, and S-[2-(06-guanyl)ethyl]glutathione at a single site. Chem. Res. Toxicol. 10: 1133–1143.
Beland, F. A. and Kadlubar, F. F. (1985) Formation and persistence of arylamine DNA adducts in vivo. Environ. Health Perspectives 62: 19–30.
Kadlubar, F. F. and Beland, F. A. (1985) Chemical properties of ultimate carcinogenic metabolites of arylamine and arylamides. In: Polycyclic Hydrocarbons and Carcinogenesis ( Harvey, R. G., ed.), American Chemical Society, Washington, DC, pp. 341–370.
Kadlubar, F. F. (1994) DNA adducts of carcinogenic aromatic amines. IARC Sci. Publ. 125: 199–216.
Kadlubar, F. F., Miller, J. A., and Miller, E. C. (1994) Hepatic microsomal N-glucuronidation and nucleic acid binding of N-hydroxy arylamines in relation to urinary bladder carcinogenesis. Cancer Res. 37: 805–814.
Wise, R. W., Zenser, T. V., Kadlubar, F. F., and Davis, B. B. (1984) Metabolic activation of carcinogenic aromatic amines by dog bladder and kidney prostaglandin H synthase. Cancer Res. 44: 1893–1897.
King, C. M., Romano, L. J. and Schuetzle, D. (eds.) (1988) Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes. Elsevier Science, New York.
Nagao, M., Wakabayashi, N. M., Ushijima, T., Toyota, M., Totsuka, Y., and Sugimura, T. (1996) Human exposure to carcinogenic heterocyclic amines and their mutationmal fingerprints in experimental animals. Environ. Health Perspectives 104: 497–501.
Gooderham, N. J., Murray, S., Lynch, A. M., Edwards, R. J., Yadollahi-Farsani, M., Bratt, C., et al. (1996) Heterocyclic amines: evaluation of their role in diet associated human cancer. Br. J. Pharmacol. 42: 91–98.
Layton, D. W., Bogen, K. T., Knize, M. G., Hatch, F. T., Johnson, V. M., and Felton, J. S. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis 16: 39–52.
Perera, F. (1997) Environment and cancer: who are susceptible? Science 278: 1068–1073.
Dipple, A., Moschel, R. C., and Bigger, A. H. (1984) Polynuclear aromatic carcinogens. In: Chemical Carcinogens, 2nd ed. (ACS Monograph 182) ( Searle, C. E., ed.), American Chemical Society, Washington DC, pp. 41–164.
Agarwal, R., Canella, K. A., Yagi, H., Jerina, D. M., and Dipple, A. (1996) Benzo[c]phenthrene-DNA adducts in mouse epidermis in relation to the tumorigenicities of four configurationally isomeric 3,4-dihydrodiol 1,2-epoxides. Chem. Res. Toxicol. 9: 586–592.
Geacintov, N. E. (1986) Is intercalation a critical factor in the covalent binding of mutagenic and tumorigenic polycyclic aromatic diol epoxides to DNA? Carcinogenesis 7: 759–766.
Loechler, E. L. (1991) Molecular modeling in mutagenesis and carcinogenesis. Methods Enzymol. 203: 458–476.
Geacintov, N. E., Cosman, M., Hingerty, B. E., Amin, S., Broyde, S., and Patel, D. J. (1997) NMR solution structures of stereoisomeric polycyclic aromatic carcinogen-DNA adducts: Principles, patterns and diversity. Chem. Res. Toxicol. 10: 111–131.
Cavalieri, E. L., Rogan, E. G., Devanesan, P. D., Cremonesi, P., Cerny, R.L., Gross, M. L., et al. (1990) Binding of benzo[a]pyrene to DNA by cytochrome P-450 catalyzed one-electron oxidation in rat liver microsomes and nuclei. Biochemistry 29: 4820–4827.
Devanesan, P. D., RamaKrishna, N. V. S., Todorovic, R., Rogan, E. G., Cavalieri, E. L., Jeong, H., et al. (1992) Identification and quantitation of benzo[a]pyrene-DNA adducts formed by rat liver microsomes in vitro. Chem. Res. Toxicol. 5: 302–309.
Chakravarti, D., Pelting, J., Cavalieri, E. L., and Rogan, E. G. (1995) Relating aromatic hydrocarbon-induced DNA adducts and the c-Hras mutations in mouse skin papillomas: The role of apurinic sites. Proc. Natl. Acad. Sci. USA 92: 10422–10426.
Chen, L., Devanesan, R., Higginbotham, S., Ariese, F., Jankowiak, R., Small, G. J., et al. (1996) Expanded analysis of benzo[a]pyreneDNA adducts formed in vitro and in mouse skin: their significance in tumor initiation. Chem. Res. Toxicol. 9: 897–903.
Todorovic, R., Ariese, F. Devanesan, R., Jankowiak, R., Small, G. J., Rogan, E. G., et al. (1997) Determination of benzo[a]pyrene-and 7,12-dimethylbenz[a]anthracene-DNA adducts formed in rat mammary glands. Chem. Res. Toxicol. 10: 941–947.
Humphreys, W. G., Kadlubar, F. F., and Guengerich, F. P. (1992) Mechanism of C8 alkylation of guanine residues by activated arylamines: evidence for initial adduct formation at the N7 position. Proc. Natl. Acad. Sci. USA 89: 8278–8282.
Patel, D. J., Mao, B., Gu, Z., Hingerty, B. E., Gorin, A., Basu, A. K., et al. (1998) Nuclear magnetic resonance solution structures of covalent aromatic amine-DNA adducts and their mutagenic relevance. Chem. Res. Toxicol. 11: 391–407.
Hoffmann, G. R. and Fuchs, R. P. (1997) Mechanisms of frameshift mutations: Insights from aromatic amines. Chem. Res. Toxicol. 10: 347–359.
Loechler, E. L. (1994) A violation of the Swain-Scott principle and not SN1 vs. SN2 reaction mechanisms, explains why carcinogenic alkylating agents can form different proportions of adducts at oxygen vs. nitrogen in DNA. Chem. Res. Toxicol. 7: 277–280.
Lawley, P. D. (1984) carcinogenesis of alkylating agents. In:Chemical Carcinogens, 2nd ed., (ACS Monograph 182), (Searle, C. E., ed.), American Chemical Society, Washington DC, pp. 325–484.
Loechler, E. L. (1991) Rotation about the C6–06 Bond in O6methylguanine: the syn and anti-conformers can be of similar energies in duplex DNA as estimated by molecular modeling techniques. Carcinogenesis 12: 1693–1699.
Dosanjh, M. K., Loechler, E. L., and Singer, B. (1993) Evidence from in vitro replication that 06-methylguanine can adopt multiple conformations. Proc. Natl. Acad. Sci. USA 90: 3983–3987.
Essigmann, J. M., Croy, R. G., Nadzan, A. M., Busby, W. F., Reinhold, V. N., Buchi, G., et al. (1977) Structural identification of the major DNA adducts formed by aflatoxin B1 in vitro. Proc. Natl. Acad. Sci. USA 74: 1870–1974.
Baiuley, G. S. (1994) Role of aflatoxin B1 adducts in the cancer process. In: The Toxicology of Aflatoxins ( Eaton, D. L. and Groopman, J. D., eds.), Academic Press, New York, pp. 137–148.
Gopalakrishnan, S., Byrd, S., Stone, M. P., and Harris, T. M. (1989) Carcinogen-nucleic acid interactions: Equilibrium binding studies of aflatoxin B1 with the oligonucleotide d(ATGCAT)2 and with plasmid pBR322 support intercalative association with the B-DNA helix. Biochemistry 28: 726–734.
Gopalakrishnan, S., Harris, T. M., and Stone, M. P. (1990) Intercalation of afaltoxin B1 in two oligodeoxynucleotide adducts: Comparative I NMR analysis of d(ATCAFBGAT):d(ATCGAT) and d(ATAFBGCAT)2. Biochemistry 29: 10438–10448.
Friedberg, E. C. Walker, G. W., and Seide, W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.
Chaney, S. G. and Sancar, A. (1996) DNA repair: enzymatic mechanisms and relevance to drug response. J. Natl. Cancer Inst. 88: 1346–1360.
Wood, R. D. (1997) Nucleotide excision repair in mammalian cells. J. Biol. Chem. 272: 23465–23468.
Wood, R. D. and Shivji, M. K. K. (1997) Which DNA polymerases are used for DNA repair in eukaryotes? Carcinogenesis 18: 605–610.
Hanawalt, P. C. (1994) Transcription-coupled repair and human disease. Science 266: 1957–1958.
Lindahl, T., Karran, P., and Wood, R. D. (1997) DNA excision repair pathways. Curr. Opin. Genet. Dev. 7: 158–169.
Scicchitano, D. A. and Mellon, I. (1997) Transcription and DNA damage: A link to a kink. Environ. Health Perspectives 105: 145153.
Krokan, H. E., Standal, R., and Slupphaug, G. (1997) DNA glycosylases in the base excision repair of DNA. Biochem. J. 325: 1–25.
Wilson, D. M., III and Thompson, L. H. (1997) Life without DNA repair. Proc. Natl. Acad. Sci. USA 95: 12754–12757.
Kunkel, T. A. and Wilson, S. H. (1996) Push and pull of base flipping. Nature 384: 25–26.
Roberts, R. (1995) On base flipping. Cell 82: 9–12.
Camerini-Otero, R. D. and Hseih, P. (1995) Homologous recombination proteins in prokaryotes and eukaryotes. Ann. Rev. Genet. 29: 509–552.
Kanaar, R. and Hoeijmakers (1998) From competition to collaboration. Nature 391: 335–336.
Hegde, S. P., Qin, M.-H., Li, X.-H., Atkinson, M. A. L., Clark, A. J., Rajagopalan, M., et al. (1996) Interactions of RecF protein with RecO, RecR, and single-stranded DNA binding proteins reveals roles for the RecF-RecO-RecR complex in DNA repair and recombination. Proc. Natl. Acad. Sci. USA 93: 14468–14473.
Dixon, D. A. and Kowalczykowski, S. C. (1993) The recombination hotspot x is a regulatory sequence that acts by attentuating the nuclease activity of the E. coli RecBCD enzyme. Cell 73: 87–96.
West, S. C. (1997) Processing of recombination intermediates by the RuvABC proteins. Ann. Rev. Genet. 31: 213–244.
Parsons, C. A., Stasiak, A., Bennett, R. J., and West, S. C. (1995) Structure of a multisubunit complex that promotes DNA branch migration. Nature 374: 375–378.
Rafferty, J. B., Sedelnikova, S. E., Hargreaves, D., Artymiuk, P. J., Baker, P. J., Sharpies, G. J., et al. (1996) Crystal structure of DNA recombination protein RuvA and a model for its binding to the Holliday junction. Science 274: 415–421.
Ariyoshi, M., Vassylyev, D. G., Iwasaki, H., Nakamura, H., Shinagawa, H., and Morikawa, K. (1994) Atomic resolution of the RuvC resolvase: a Holliday junction-specfic endonuclease from E. coli. Cell 78: 1063–1072.
Wang, G., Rahman, W. S., and Humayun, M. Z. (1997) Replication of M13 single-stranded viral DNA bearing single site-specfic adducts by Escherichia coli cell extracts: differential efficiency of translesion DNA synthesis for SOS-dependent and SOS-independent lesions. Biochemistry 36: 9486–9492.
Palewala, V. A., Pandya, G. A., Bhanot, O. S., Solomon, J. J., Murphy, II. S., Dunman, P. M., et al. (1994) UVM, an ultraviolet-inducible RecA-independent mutagenic phenomenon in Escherichia coli. J. Biol. Chem. 269: 27433–27440.
Napolitano, R. L., Lambert, I. B., and Fuchs, R. P. (1997) SOS factors involved in translesion synthesis. Proc. Natl. Acad. Sci. USA 94: 5733–5738.
Dynan, W. S. and Yoo, S. (1998) Interaction of Ku protein and DNA-dependent protein kinase catalytic subunit with nucleic acids. Nucleic Acids Res. 26: 1551–1559.
Jin, S., Inoue, S., and Weaver, D. T. (1997) Functions of the DNA dependent protein kinase. Cancer Surv. 29: 221–261.
Jeggo, P. A. (1997) DNA-PK at the cross-roads of biochemistry and genetics. Mut. Res. 384: 1–14.
Jackson, S. P. (1997) DNA-dependent protein kinase. Int. J. Biochem. Cell Biol. 29: 935–938.
Lieber, M. R., Grawunder, U., Wu, X., and Yaneva, M. (1997) Tying up loose ends: roles for Ku and DNA-dependent protein kinase in the repair of double-strand breaks. Curr. Opin. Genet, Dev. 7: 99–104.
Hendrickson, E. A. (1997) Cell-cycle regulation of mammalian DNA double-strand-break repair. Am. J. Human Genet. 61: 795–800.
Stahl, F. (1996) Meiotic recombination in yeast: Coronation of the double-strand-break repair model. Cell 87: 965–968.
Dolganov, G. M., Maser, R. S., Novikov, A., Tosto, L., Chong, S., Brtessan, D. A., et al. (1996) Human Rad50 is physically associated with human Mrel l: identification ofa conserved multiprotein complex implicated in recombinational repair. Mol. Cell Biol. 16: 4832–4841.
Maser, R. S., Monson, K. J., Nelms, B. E., and Petrini, J. H. (1997) hMrel l and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol. Cell Biol. 17: 6087–6096.
Johzhuka, K. and Ogawa, H. (1995) Interaction of Mrel l and Rad50: two proteins required for DNA repair and meiosis-specific double-srand break formation in Saccharamoyces cerevisiae. Genetics 139: 1521–1532.
Murane, J. P. (1996) Role of induced genetic instability in the mutagenic effects of chemicals and radiation. Mut. Res. 367: 11 23.
Kronenberg, A. (1994) Radiation-induced genomic instability. Int. J. Rad. Biol. 66: 603–609.
Solomon, E., Borrow, J., and Goddard, A. D. (I 991) Chromosome aberrations and cancer. Science 254: 1153–1160.
Rabbitts, T. H. (1994) Chromosomal translocations in human cancer. Nature 372: 143–149.
Chang, W. P. and Little, J. B. (1992) Persitently elevated frequency of spontaneous mutations in progeny of CHO cells surviving X-irradiation: association with delayed reproductive death phenotype. Mut. Res. 270: 191–199.
Grosovsky, A. J., Parks, K. K., Giver, C. R., and Nelson, S. L. (1996) Clonal analysis of delayed karyotypic abnormalities and gene mutations in radiation-induced genetic instability. Mol. Cell Biol. 16: 6252–6262.
Holmberg, K., Meijer, A. E., Auer, G., and Lambert, B. O. (1995) Delayed chromosomal instability in human T-lymphocyte clones exposed to ionizing radiation. Int. J. Rad. Biol. 68: 245–255.
Holmberg, K., Fah, S., Johansson, A., and Lambert, B. (1993) Clonal chromosomal aberrations and genomic instability in X-irradiated human T-lymphocyte cultures. Mut. Res. 286: 321–330.
Pardee, A. B. (1989) G 1 events and regulation of cell proliferation. Science 240: 603–608.
Hartwell, L. H. and Kastan, M. B. (1994) Cell cycle control and cancer. Science 266: 1821–1828.
Paulovich, A. G., Toczyski, D. P., and Hartwell, L. H. (1997) When checkpoints fail. Cell 88: 315–321.
Sherr, C. J. (1993) Mammalian GI cyclins. Cell 73: 1059–1065.
Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81: 323–330.
Weinberg, R. A. (1996) E2F and cell proliferation: a world turned upside down. Cell 85: 457–459.
Herwig, S. and Strauss, M. (1997) The Rb protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 246: 581–601.
Hunter, T. (1997) Oncoprotein networks. Cell 88: 333–346.
Collins, K., Jacks, T., and Pavletich, N. P. (1997) The cell cycle and cancer. Proc. Natl. Acad. Sci. USA 94: 2776–2778.
Elledge, S. J. (1996) Cell cycle checkpoints: preventing an idenitity crisis. Science 274: 1664–1672.
Levine, A. J. (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
Bjelogrlic, N. M., Mäkinen, M., Stenbäck, and Vähäkangas, K. (1994) Benzo[a]pyrene-7,8-dio1–9,10-epoxide-DNA adducts and increased p53 protein in mouse skin. Carcinogenesis 15: 771–774.
Khan, Q. A., Vousden, K. H., and Dipple, A. (1997) Cellular response to DNA damage from a potent carcinogen involves stabilization ofp53 without induction of p21 (wafl/cipl). Carcinogenesis 18: 2313–2318.
Vaziri, C. and Faller, D. V. (1997) A benzo[a]pyrene-induced cell cycle checkpoint resulting in p53-independent G1 arrest in 3T3 fibroblasts. J. Biol. Chem. 272: 2762–2769.
Hengartner, M. O. (1998) Death cycle and Swiss army knives. Nature 391: 441–442.
Wertz, I. E. and Hanley, M. R. (1996) Diverse molecular provocation of programmed cell death. Trends Biol. Res. 21: 359–364.
Nagata, S. (1997) Apoptosis by death factor. Cell 88: 355–365.
Cohen, G. M. (1997) Caspases: the executioners of apoptosis. Biochem. J. 326: 1–16.
Wyllie, A. (1998) An endonuclease at last. Nature 391: 20–21.
Vuax, D. L. and Strasser, A. (1996) The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93: 2239–2244.
Hale, A. J., Smith, C. A., Sutherland, L. C., Stoneman, V. E. A., Longhorn, V. L., Culhane, A. C., et al. (1996) Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236: 1–26.
White, E. (1996) Life, death, and the pursuit of apoptosis. Genes Develop. 10: 1–15.
Peter, M. E., Heufelder, A. E., and Hengartner, M. O. (1997) Advances in apoptosis research. Proc. Natl. Acad. Sci. USA 94: 12736–12737.
Kerr, A. H., Wylie, J. F., and Currie, A. R. (1972) Apoptosis: abasic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26: 239–257.
Jacobson, M. D. (1996) Reactive oxygen species and programmed cell death. Trends Biol. Res. 21: 83–86.
Kinzler, K. W. and Vogelstein, B. (1996) Life (and death) in a malignant tumor. Nature 379: 19–20.
Muchmore, S. W., Sattlet, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., et al. (1996) X-ray and NMR structure of human Bcl-xL an inhibitor of programmed cell death. Nature 381: 335–341.
Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., et al. (1996) Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183: 1533–1544.
Vander Heiden, V., Chandel, N. S., Williamson, E. K., Schumacker, P. T. and Thompson, C. B. (1997) Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 91: 627–637.
Salvesen, G. S. and Dixit, V. M. (1997) Caspases: intracellular signaling by proteolysis. Cell 91: 443–446.
Hampton, M. B., Zhivotsky, B., Slater, A. F. G., Burgess, D. H., and Orrenius, S. (1998) Importance of the redox state of cytochrome C during caspase activation in cytosolic extracts. Biochem. J. 329: 95–99.
Kluck, R. M., Martin, S. J., Hoffman, B. M., Zhou, J. S., Green, D. R., andNewmeyer, D. D. (1997) Cytochrome c activation ofCPP32like proteolysis plays a critical role in a Xenopus cell-free apoptosis system. EMBO J. 16: 4639–3649.
Oren, M. (1998) Teaming up to restrain cancer. Nature 391: 233–234.
Yin, Y., Terauchi, Y., Solomon, G. S., Aizawa, S., Rangarajan, P. N., Yazaki, Y., et al. (1998) Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391: 707–710.
Loechler, E. L. (1994) Mechanism by which aflatoxins and other bulky carcinogens induce mutations. In: The Toxicology ofAflatoxins: Human Health, Veterinary, and Agricultural Significance ( Eaton, D. L. and Groopman, J.D., eds.), Academic Press, Orlando, FL, pp. 149–178.
Miller, J. H. (1983) Mutational specificity in bacteria. Ann. Rev. Genet. 17: 215–238.
Rodriguez, H. and Loechler, E. L. (1993) Mutational spectra of the (+)-anti-diol epoxide of benzo[a]pyrene in a supF gene of an Escherichia coli plasmid: DNA sequence context influences hotspots, mutational specficity and the extent of SOS enhancement of mutagenesis. Carcinogenesis 14: 373–383.
Rodriguez, H. and Loechler, E. L. (1993) Mutagenesis by the (+)anti-diol epoxide of benzo[a]pyrene: What controls mutagenic specificity? Biochemistry 32: 373–383.
Wei, S.-J. C., Chang, R. L., Wong, C.-Q., Bhachech, N., Cui, X. X., Hennig, E., et al. (1991) Dose-dependent differences in the profile of mutations induced by an ultimate carcinogen from benzo[a]pyrene. Proc. Natl. Acad. Sci. USA 88: 11227–11230.
Wei, S.-J. C., Chang, R. L., Bhachech, N., Cui, X. X., Merkler, K. A., Wong, C. Q., et al. (1993) Dose-dependent differences in the profile of mutations induced (+)-7R,8S-dihydroxy-9S,10R-epoxy7,8,9,10-tetrahydrobenzo[a]pyrene in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene in Chinese hampster V79 cells. Cancer Res. 53: 3294–3301.
Wei, S.-J. C., Chang, R. L., Hennig, E., Cui, X. X., Merkler, K. A., Wong, C.-Q., et al. (1994) Mutagenic selectivity at the HPRT locus in V-79 cells: comparison of mutations caused by bay-region benzo[a]pyrene 7,8-dio1–9,10-epoxide enantiomers with high and low carcinogenic activity. Carcinogenesis 15: 1729–1735.
Wei, S.-J. C., Chang, R. L., Cui, X. X., Merkler, K. A., Wong, C.-Q., Yagi, H., et al. (1996) Dose-dependent differences in the mutational profiles of (-)-(1R,2S,3S,4R)-3,4-dihydroxy-1,2-epoxy1,2,3,4-tetrahydrobenzo[c]phenanthrene and its less carcinogenic enantiomer. Cancer Res. 56: 3695–3703.
Bigger, C. A. H., St. John, J., Yagi, H., Jerina, D. M., and Dipple, A. (1992) Mutagenic specificities of four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides. Proc. Natl. Acad. Sci. USA 89: 368–372.
D’Ayala, M., Cui, X. X., Merkler, K. A., Wong, C.-Q., Yagi, H., Jerina, D. M., et al. (1998) Lack of dose dependence in mutation profile induced by (+)-7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10tetrahydrobenzo[a]pyrene [(+)-BPDE] at the hprt gene in repair deficient Chinese hampster V-H1 cells. Proc. Am. Assoc. Cancer Res. 39: 639a.
Singer, B. and Essigmann J. M. (1991) Site-specific mutagenesis: retrospective and prospective. Carcinogenesis 12: 949–955.
Loechler, E. L. (1996) Commentary: The role of adduct site-specific mutagenesis in understanding how carcinogen DNA adducts cause mutations: perspective, prospects and problems. Carcinogenesis 17: 895–902.
Mackay, W., Benasutti, M., Drouin, E., and Loechler, E. L. (1992) Mutagenesis by the major adduct of activated benzo[a]pyrene, (+)anti-BP-N2-Gua, when studied in an Escherichia coli plasmid using site-directed methods. Carcinogenesis 13: 1415–1425.
Jelinsky, S. A., Mao, B., Geacintov, N. E., and Loechler, E. L. (1995) The major, N2-Gua adduct of the (+)-anti-benzo[a]pyrene diol epoxide is capable of inducing GEA and GEC, in addition to GET, mutations. Biochemistry 34: 13545–13553.
Shukla, R., Liu, Y., Geacintov, N., and Loechler, E. L. (1997) The major, N2-dG adduct of (+)-anti-B[a]PDE shows a dramatically different mutagenic specificity (predominantly, GEA) in a 5’-CGT3’ sequence context. Biochemistry 36: 10256–10261.
Shukla, R, Jelinsky, S., Liu T., Geacintov, N. E., and Loechler, E. L. (1997) How stereochemistry affects mutagenesis by N2-dG adducts of B[a]PDE: configuration of the adduct bond is more important than of the hydroxyl groups. Biochemistry 36: 13263–13269.
Moriya, M., Spiegel, S., Fernandes, A., Amin, S., Liu, T.-M., Geacintov, N. E., et al. (1996) Fidelity of translesion synthesis past benzo[a]pyrene diol epoxide-2’-deoxyguanosine DNA adducts: marked effects of host cell, sequence context, and chirality. Biochemistry 35: 16646–16651.
Fuchs, R. P. P. (1985) DNA binding spectrum of the carcinogen Nacetoxy-N-2-acetylaminofluorene significantly differs from the mutation spectrum. J. Mol. Biol. 177: 173–180.
Reid, T. M., Lee, M.-S., and King, C. M. (1990) Mutagenesis by site-specific arylamine adducts in plasmid DNA: enhancing replication of the adducted strand alters mutation frequency. Biochemistry 29: 6153–6161.
Burnout’, D., Koehl, P., and Fuchs, R. P. P. (1989) Single adduct mutagenesis: Strong effect of the position of a single acetylaminofluorene adduct within a mutation hot spot. Proc. Natl. Acad. Sci. USA 86: 4147–4151.
Seeberg, E. and Fuchs, R. P. P. (1990) Acetylaminofluorene bound to different guanines of the sequence -GGCGCC- is excised with different efficiencies by the UvrABC exicision nuclease in a pattern not correlated to the potency of mutation induction. Proc. Natl. Acad. Sci. USA 87: 191–194.
Delagoutte, E., Bertrand-Burggraf, E., Dunand, J., and Fuchs, R. P. (1997) Sequence-dependent modulation of nucleotide excision repair: the efficiency of the incision reaction correlated with the stability of the pre-incision UvrB-DNA complex. J. Mol. Biol. 266: 703–710.
Lambert, I. B., Napolitano, R. L., and Fuchs, R. P. P. (1992) Carcinogen-induced frameshift mutagenesis in repetitive equences. Proc. Natl. Acad. Sci. USA 89: 1310–1314.
Napolitano, R. L., Lambert, I. B., and Fuchs, R. P. P. (1994) DNA sequence determinants of carcinogen-induced frameshift mutagenesis. Biochemistry 33: 1311–1315.
Koffel-Schwartz, N., Coin, F., Veaute, X., and Fuchs, R. P. (1996) Cellular strategies for accomodating replication-hindering adducts in DNA: control by the SOS response in Escherichia coli. Proc. Natl. Acad. Sci. USA 93: 7805–7810.
Ezaz-Nikpay, K. and Verdine, G. L. (1994) The effects of N7methylguanine on duplex DNA structure. Chem. Biol. 1: 235–240.
Bhanot, O. P., Grevatt, P. C., Donahue, J. M., Gabrielides, C. N., and Solomon, J. J. (1992) In vitro DNA replication implicates O2ethyldeoxythymidine in transversion mutagenesis by ethylating agents. Nucleic Acids Res. 20: 587–594.
Kunkel, T. A. (1984) Mutational specificity of depurination. Proc. Natl. Acad. Sci. USA 81: 1494 1498.
Lawrence, C. W., Borden, A., Banerjee, S. K., and LeClerc, J. E. (1990) Mutation frequency and spectrum resulting from a single abasic site in a single-stranded vector. Nucleic Acids Res. 18: 2153–2157.
Bailey, E. A., Iyer, R. S., Stone, M. P., Harris, T. M., and Essigmann, J. M. (1996) Mutational properties of the primary aflatxoin B1-DNA adduct. Proc. Natl. Acad. Sci. USA 93: 1535–1539.
Kunkel, T. A. and Wilson, S. H. (1998) DNA polymerases on the move. Nature Struct. Biol. 5: 95–103.
Cooper, G. M. (1995) Oncogenes, 2nd ed. Jones and Bartlett, London.
Cooper, D. N. and Krawczak, M. (1993) Human Gene Mutations. BIOS Scientific Publishers Limited, London UK.
Nagase, H. and Nakamura, Y. (1993) Mutations of the APC (Adenomatous Polyposis Coli) gene. Human Mut. 2: 425–434.
Coulondre, C., Miller, J. H., Farabaugh, P. J., and Gilbert, W. (1978) Molecular basis of base substitution hotspots in Escherichia coli. Nature 278: 775–780.
Duncan, B. K. and Miller, J. H. (1980) Mutagenic deamination of cytosine residues in DNA. Nature 287: 560–565.
Schaaper, R. M. and Dunn, R. L. (1987) Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch corrections: the nature of in vivo DNA replication errors. Proc. Natl. Acad. Sci. USA 84: 6220–6224.
Schaaper, R. M. and Dunn, R. L. (1991) Spontaneous mutation in the Escherichia coli strains lacl gene. Genetics 129: 317–326.
Brash, D. E., Rudolph, J. A., Simon, J. A., Lin, A., McKenna, G. J., Baden, H. P., et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88: 10124–10128.
Dumaz, N., Stary, A., Soussi, T., Daya-Grosjean, L., and Sarasin, A. (1994) Can we predict solar ultraviolet radiation as the causal event in human tumors by analyzing the mutation spectra of the p53 gene? Mut. Res. 307: 375–386.
Daya-Grosjean, L. Dumaz, N., and Sarasin, A. (1995) The specificity of p53 mutation spectra in sunlight induced human cancers. J. Photochem. Photobiol. 28: 115–124.
D’errico, M., Calcagnile, A., and Dogliotti, E. (1996) Genetic alterations in skin cancer. Ann. 1st. Super. Sanita 32: 53–63.
Miller, J. H. and Reznikoff, W. S., eds. (1980) The Operon, 2nd ed., Cold Spring Harbor Press, Cold Spring Harbor, NY.
Miller, J. H. (1983) Mutagenic specificity in bacteria. Ann. Rev. Genet. 17: 215–238.
Miller, J. H. (1985) Mutagenic specificity of ultraviolet light. J. Mol. Biol. 182: 45–65.
Hsia, H. C., Lebkowski, J. S., Leong, P. M., Calos, M. P., and Miller, J. H. (1989) Comparison of ultraviolet irradiation-induced mutagenesis of the lad gene in Escherichia coli and in human 293 cells. J. Mol. Biol. 205: 103–113.
Denissenko, M. F., Pao, A., Tang, M., and Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430–432.
Denissenko, M. F., Pao, A., Pfeifer, G. P., and Tang, M.-S. (1998) Slow repair of bulky DNA adducts along thre nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers. Oncogene 16: 1241–1247.
El-Bayoumy, K. (1992) Environmental carcinogens that may be involved in human breast cancer etiology. Chem. Res. Toxicol. 5: 585–590.
Klein, C. B., Snow, E. T., and Frenkel, K. (1998) Molecular mechanisms in metal carcinogenesis: Role of oxidative stress. In: Molecular Biology of Free Radicals in Human Diseases ( Aruoma, O. I. and Halliwell, B., eds.), OICA International, Santa Lucia, West Indies, pp. 80–137.
Klein, C. B. (1996) Carcinogenicity and genotoxicity of chromium. In: Toxicology of Metal ( Magos, L. and Suzuki, T., eds.), CRC Press, Boca Raton, FL.
Snow, E. T. (1992) Metal carcinogenesis: mechanistic implications. Pharmacol. Ther. 53: 31–65.
Snow, E. and Costa, M. (1998) Nickel toxicity and carcinogenesis. In: Environmental and Occupational Medicine, 3rd ed. ( Rom, W.N., ed.), Lippincott-Raven, Philadelphia, PA.
Mossman, B. T., Faux, S., Janssen, Y., Jimenez, L. A., Timblin, C., Zanella, C., et al. (1997) Cell signalling pathways elicited by asbestos. Environ. Health Perspect. 105: 1 121–1125.
Boutwell, R. K. (1964) Some biological aspects of skin carcinogenesis. Prog. Exp. Tumor Res. 4: 207–250.
Boutwell, R. K. (1974) The function and mechanism of promoters of carcinogens. CRC Crit. Rev. Toxicol. 2: 419–443.
Boutwell, R. K. (1985) Tumor promoters in human carcinogenesis. Important. Adv. Oncol. 1985: 16–27.
Slaga, T. J. and DiGiovanni, J. (1984) In: Chemical Carcinogens, 2nd ed. (ACS Monograph 182), (Searle, C. E., ed.), American Chemical Society, Washington DC, pp. 1279–1321.
Slaga, T. J., DiGiovanni, J., Winberg, L. D., and Budunova, I. V. (1995) Skin carcinogenesis: characteristics, mechanisms, and prevention. Prog. Clin. Biol. Res. 391: 1–20.
Kensler, T., Guyton, K., Egner, P., McCarthy, T., Lesko, S., and Akman, S. (1995) Role of reactive intermediates in tumor promotion and progression. Prog. Clin. Biol. Res. 391: 103–116.
Nishizuki, Y. (1984) The role of protein kinase C in cell surface signal transduction and tumor promotion. Nature 308: 693–698.
El-Shemerly, M. Y., Besser, D., Nagasawa, M., and Nagamine, Y. (1997)12-O-tetradecanoylphorbol-13-acetate activates the Ras/extracellular signal-regulated kinase (ERK) signaling pathway upstream of SOS involving serine phosphorylation of Shc in NIH3T3 cells. J. Biol. Chem. 272: 30599–30602.
Kuroki, D. W., Bignami, G. S., and Wattenberg, E. V. (1996) Activation of stress-activated protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin. Cancer Res. 56: 637–644.
Dong, Z., Crawford, H. C., Lavrovsky, V., Taub, D., Watts, R., Matrisian, L. M., and Colburn, N. H. (1997) A dominant negative mutant of jun blocking 12-O-tetradecanoylphorbol-13-acetate-induced invasion in mouse keratinocytes. Mol. Carcinogenesis 19: 204–212.
Dong, Z., Lavrovsky, V., and Colbum, N. H. (1995) Transversion reversion induced in JB6 RT 101 cells by AP-1 inhibitors. Carcinogenesis 16: 749–756.
Bernstein, L. R. and Colburn, N. H. (1989) AP-1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 244: 566–569.
Ransome, L.J. and Verma, I. M. (1990) Nuclear proto-oncogenes FOS and JUN. Ann. Rev. Cell Biol. 6: 539–557.
Kuroki, D. W., Minden, A., Sanchez, I., and Wattenberg, E. V. (1997) Regulation of a c-Jun amino-terminal kinase/stress-activated protein kinase cascade by a sodium-dependent signal transduction pathway. J. Biol. Chem. 272: 23905–23911.
Suganuma, M., Fujiki, H., Suguri, H., Yoshizawa, S., Hirota, M., Nakayasu, M., et al. (1988) Okadaic acid: An additional nonphorbol-12-tetradecanoate-13-acetate-type tumor promoter. Proc. Natl. Acad. Sci. USA 85: 1768–1771.
Nagao, M., Sakai, R., Kitagawa, Y., Ikeda, I., Sasaki, K., Shima, H., et al. (1989) Role of protein phosphatases in malignant transformation. Princess Takamatsu Symp. 20: 177–184.
Schonthal, A., Tsukitani, Y., and Feramisco, J. R. (1991) Transcriptional and post-translational regulation of c-fos expression by the tumor promoter okadaic acid. Oncogene 6: 423–430.
Peng, J., Bowden, G. T., and Domann, F. E. (1997) Activation of AP-1 by okadaic acid in mouse keratinocytes associated with hyperphorphorylation of c-jun. Mol. Carcinogenesis 18: 37–43.
Willis, I., Menter, J. M., and Whyte, H. J. (1981) The rapid induction of cancers in the hairless mouse utlizing the principle of photoaugmentation. J. Invest. Dermatol. 76: 404–408.
Strickland, P. T. (1986) Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sancar mice. J. Invest. Dermatol. 87: 272–278.
Ronai, Z. A., Lambert, M. E., and Weinstein, I. B. (1990) Inducible cellular responses to ultraviolet irradiation and other mediators of DNA damage in mammalian cells. Cell Biol. Toxicol. 6: 105–126.
Angel, P. (1995) The role and regulation of the Jun proteins in response to phorbol esters and UV light. In: Inducible Gene Expression, ( Baeuerle, P. A., ed.), Birkhauser, Boston, pp. 62–92.
Melikian, A. A., Leszczynska, J. M., Hecht, S. S., and Hoffmann, D. (1986) Effects of the co-carcinogen catechol on benzo[a]pyrene metabolism and DNA adduct formation in mouse skin. Carcinogenesis 7: 9–15.
Lau, H. H. and Baird, W. M. (1992) The co-carcinogen benzo[e]pyrene increases the binding of a low dose of the carcinogen benzo[a]pyrene to DNA in Sencar mouse epidermis. Cancer Lett. 63: 229–236.
Reed, G.A. and Jones, B.C. (1996) Enhancement ofbenzo[a]pyrene diol epoxide mutagenicity by sulfite in a mammalian test system. Carcinogenesis 17: 1063–1068.
Friedberg, E.C., Feaver, W.J. and Gerlach, V.L. (2000) The many faces of DNA polymerases: strategies for mutagenesis and for mutational avoidance. Proc. Natl. Acad. Sci USA, 97: 5681–5683.
Johnson, R.E., Washington, M.T., Prakash, S. and Prakash, L. (1999) Bridging the gap: a family of novel DNA polymerases that replicate faulty DNA. Proc. Natl. Acad. Sci. USA, 96: 12224–12226.
Goodman, M.F. and Tippin, B. (2000) Sloppier copier DNA polymerases involved in genome repair. Curr. Opin. Genet. Dev. 10: 162–168.
Yu, S.L., Johnson, R.E., Prakash, S. and Prakash, L. (2001) Requirement of DNa polymerise eta for error-free bypass of UV-inuduced CC and TC photoproducts Mol. Cell. Biol. 21: 185–188.
Gibbs, P.E., Wang, X.D., Li, Z., McManus, T.P., McGregor, W.G., Lawrence, C.W. and Maher, V.M. (2000) The function of the human homolog of Secharomyces cerevisiae REV1 is required for mutagenesis induced by UV light. Proc. Natl. Acad. Sci. USA 97: 4186–4191.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Loechler, E.L., Henry, B., Seo, KY. (2002). Cellular Responses to Chemical Carcinogens. In: Coleman, W.B., Tsongalis, G.J. (eds) The Molecular Basis of Human Cancer. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-125-1_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-125-1_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-107-3
Online ISBN: 978-1-59259-125-1
eBook Packages: Springer Book Archive